Neoplasene

Neoplasene is a botanical extract derived from the Bloodroot plant (Sanguinaria canadensis). It is primarily used in veterinary medicine for the treatment of cancer in animals, particularly dogs and cats.

History

Neoplasene was developed by Dr. Terry Fox, a veterinarian who specialized in oncology. He discovered the potential anti-cancer properties of the bloodroot plant and developed Neoplasene as a treatment option for pets with various forms of cancer.

Composition

Neoplasene is a mixture of several alkaloids, the most active of which is sanguinarine. Sanguinarine has been shown to have anti-cancer properties in several in vitro studies.

Mechanism of Action

Neoplasene works by causing apoptosis, or programmed cell death, in cancer cells. It does this by disrupting the mitochondria, the energy-producing structures within cells, which leads to cell death.

Usage

Neoplasene can be used both topically and internally. Topical application is used for external tumors, while internal use is recommended for systemic cancers. The exact dosage and method of administration depend on the type and stage of cancer, as well as the individual animal's overall health.

Side Effects

Like all treatments, Neoplasene can have side effects. These can include local irritation or inflammation at the site of topical application, and gastrointestinal upset with internal use. In rare cases, severe allergic reactions can occur.

Research and Efficacy

While there is anecdotal evidence supporting the efficacy of Neoplasene in treating animal cancers, more rigorous scientific research is needed. Some studies have shown promising results, but these have been small-scale and often lack control groups.

Conclusion

Neoplasene represents a potentially promising treatment for animal cancers. However, pet owners should consult with a qualified veterinarian before starting any new treatment regimen.